Protein spherulites for sustained release of interferon: Preparation, characterization and in vivo evaluation

Journal of Pharmaceutical Sciences

Volumn 100, Issue 5, 2011, Pages 1913-1922

  Jiang, Yanbo ^a   Shi, Kai ^a   Xia, Dengning ^a   Wang, Shuo ^a   Song, Tao ^b   Cui, Fude ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Liaoning Satellite Biotechnology Products Research Institute (Limited Company)   (China)

Author keywords

Controlled release; Crystals; Injectables; Pharmacokinetics; Protein delivery

Indexed keywords

ANION; RECOMBINANT ALPHA2B INTERFERON; ZINC DERIVATIVE;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG RELEASE; DRUG SCREENING; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TEMPERATURE; NONHUMAN; PH; PROTEIN AGGREGATION; PROTEIN SPHERULITE; RABBIT; SUSTAINED DRUG RELEASE;

EID: 79952229900     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22403     Document Type: Article

References (32)

1. Magill JH. 2001. Spherulites: A personal perspective. J Mater Sci 36:3143-3164.
2. Linden Evd, Venema P. 2007. Self-assembly and aggregation of proteins. Curr Opin Colloid Interface Sci 12:158-165.
3. Chow PS, Zhang J, Liu XY, Tan RBH. 2002. Spherulitic growth in protein solutions. Int J Mod Phys B 16(1-2):354-358.
4. Krebs MRH, MacPhee CE, Miller AF, Dunlop IE, Dobson CM, Donald AM. 2004. The formation of spherulites by amyloid fibrils of bovine insulin. Proc Natl Acad Sci U S A 101(40):14420-14424.
5. Krebs MRH, Bromley EHC, Rogers SS, Donald AM. 2005. The mechanism of amyloid spherulite formation by bovine insulin. Biophys J 88(3):2013-2021.
6. Domike KR, Donald AM. 2009. Kinetics of spherulite formation and growth: Salt and protein concentration dependence on proteins beta-lactoglobulin and insulin. Int J Biol Macromol 44(4):301-310.
7. Coleman JE, Allan BJ, Vallee BL. 1960. Protein spherulites. Science 131:350-352.
8. Yagi N, Ohta N, Matsuo T. 2009. Structure of amyloid fibrils of hen egg white lysozyme studied by microbeam X-ray diffraction. Int J Biol Macromol 45(1):86-90.
9. Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JU. 1984. Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med 310:15-18.
10. Muss HB. 1987. Interferon therapy for renal cell carcinoma. Semin Oncol 14:36-42.
11. Samuel CE. 2001. Antiviral actions of interferons. Clin Microbiol Rev 14:778-809.
12. Sánchez A, Tobío M, González L, Fabra A, Alonso MJ. 2003. Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. Eur J Pharm Sci 18:221-229.
13. Qiu J, Wei XH, Geng F, Liu R, Zhang JW, Xu YH. 2005. Multivesicular liposome formulations for the sustained delivery of interferon alpha-2b. Acta Pharmacol Sin 26:1395-1401.
14. Grace M, Youngster S, Gitlin G, Sydor W, Xie L, Westreich L, Jacobs S, Brassard D, Bausch J, Bordens R. 2001. Structural and biologic characterization of pegylated recombinant IFN-alpha2b. J. Interferon Cytokine Res 21:1103-1115.
15. Glue P, Fang JW, Rouzier-Panis R, Raffanel C, Sabo R, Gupta SK, Salfi M, Jacobs S. 2000. Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group. Clin Pharmacol Ther 68:556-567.
16. Foser S, Schacher A, Weyer KA, Brugger D, Dietel E, Marti S, Schreitmüller T. 2003. Isolation, structural characterization, and antiviral activity of positional isomers of monopegylated interferon α-2a (PEGASYS). Protein Expr Purif 30:78-87.
17. Domike KR, Donald AM. 2007. Thermal dependence of thermally induced protein spherulite formation and growth: Kinetics of beta-lactoglobulin and insulin. Biomacromolecules 8(12):3930-3937.
18. Rogers SS, Krebs MR, Bromley EH, van der Linden E, Donald AM. 2006. Optical microscopy of growing insulin amyloid spherulites on surfaces in vitro. Biophys J 90(3):1043-1054.
19. Rubinstein S, Familletti PC, Pestka S. 1981. Convenient assay for interferons. J Virol 37(2):755-758.
20. Santana H, Espino Y, Franco A, Furrazola G, Hardy E. 1999. A sandwich-type enzyme-linked immunosorbent assay for the analysis of recombinant human interferon α-2b. Biotech Tech 5:341-346.
21. Perutz MF, Finch JT, Berriman J, Lesk A. 2002. Amyloid fibers are water-filled nanotubes. Proc Natl Acad Sci U S A 99(8):5591-5595.
22. Dong J, Shokes JE, Scott RA, Lynn DG. 2006. Modulating amyloid self-assembly and fibril morphology with Zn(II). J Am Chem Soc 128(11):3540-3542.
23. Radhakrishnan R, et al. 1996. Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography. Structure 4:1453-1463.
24. Krebs MRH, Domike KR, Donald AM. 2009. Protein aggregation: More than just fibrils. Biochem Soc Trans 37:682-686.
25. Khurana R, Gillespie JR, Talapatra A, Minert LJ, Ionescu-Zanetti C, Millett I, Fink AL. 2001. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 40:3525-3535.
26. Nielsen L, Khurana R, Coats A, Frokjaer S, Brange J, Vyas S, Uversky VN, Fink AL. 2001. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 40(20):6036-6046.
27. Gietz U, Arvinte T, Mader E, Oroszlan P, Merkle HP. 1998. Sustained release of injectable zinc-recombinant hirudin suspensions: Development and validation of in vitro release model. Eur J Pharm Biopharm 45(3):259-264.
28. Prabhu S, Jacknowitz AI, Stout PJ. 2001. A study of factors controlling dissolution kinetics of zinc complexed protein suspensions in various ionic species. Int J Pharm 217(1-2):71-78.
29. Dobson CM. 2003. Protein folding and misfolding. Nature 426(6968):884-890.
30. Bai F, Zeng C, Yang S, Zhang Y, He Y, Jin J. 2008. The formation of a novel supramolecular structure by amyloid of poly-l-glutamic acid. Biochem Biophys Res Commun 369(3):830-834.
31. Zhang SG. 2003. Fabrication of novel biomaterials through molecular self-assembly. Nat Biotechnol 21:1171-1178.
32. Aggeli A, Bell M, Carrick LM, Fishwick CW, Harding R, Mawer PJ, Radford SE, Strong AE, Boden N. 2001. pH as a trigger of peptide β-sheet self-assembly and reversible switching between nematic and isotropic phases. J Am Chem Soc 125:9619-9628.